Accordingly, we reasoned that anti-AT1R and anti-ETAR Abs could directly contribute to the initiation of inflammation and fibrosis in vitro and in vivo by activation of endothelial cells, fibroblasts, and neutrophils and thus contribute to the key pathogenic manifestations of SSc. This evidence concerns the gene AGTR1 and systemic sclerosis.